Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Elisa Roldan Galvan

6PUBLICATIONS
59CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesAutoimmunityRegenerative medicine (incl. stem cells)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|Sep 30, 2025
BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party.

Raffaella Greco, Riccardo Saccardi, Marta Ponzano

|Aug 19, 2025
Autologous haematopoietic stem cell transplantation for rheumatic diseases: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee.

Tobias Alexander, Elisa Roldan, Nicoletta Del Papa

|Jul 07, 2025
Aggressive MS and Autologous HSCT: A review on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation.

Giacomo Boffa, Angela Genchi, Alice Mariottini

|Feb 05, 2024
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial.

Gavin Brittain, Jennifer Petrie, Kate E M Duffy

|Nov 29, 2021
Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies.

Moraima Jiménez, Elisa Roldán, Candela Fernández-Naval

|Jul 14, 2020
Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis.

María Laura Fox, Irene García-Cadenas, Ariadna Martínez Pérez

Pageof 1

Frequent Collaborators

3 joint publications

John A Snowden

2 joint publications

María Laura Fox

2 joint publications

Guillermo Villacampa

2 joint publications

Alice Mariottini

2 joint publications

Raffaella Greco

2 joint publications

Tobias Alexander

2 joint publications

Jaime Sanz

1 joint publications

Irene García-Cadenas

1 joint publications

Juan Montoro

1 joint publications

Rodrigo Martino

Frequent Collaborators

3 joint publications

John A Snowden

2 joint publications

María Laura Fox

2 joint publications

Guillermo Villacampa

2 joint publications

Alice Mariottini

Top Related Videos

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on : Feb 16, 2024

885
See more related videos

Top Related Videos

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on : Feb 16, 2024

885
See more related videos